Therapeutic drug monitoring enables safe and effective lenalidomide therapy in patients with multiple myeloma on hemodialysis
Crossref DOI link: https://doi.org/10.1007/s00277-016-2809-5
Published Online: 2016-09-06
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kobayashi, Takahiro
Niioka, Takenori
Miura, Masatomo
Takahashi, Naoto
License valid from 2016-09-06